Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction

International Journal of Antimicrobial Agents

Volumn 36, Issue 2, 2010, Pages 179-181

  Matsumoto, Kazuaki ^a   Takeshita, Ayumi ^a   Ikawa, Kazuro ^b   Shigemi, Akari ^a   Yaji, Keiko ^a   Shimodozono, Yoshihiro ^a   Morikawa, Norifumi ^b   Takeda, Yasuo ^a   Yamada, Katsushi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Linezolid; Pharmacokinetics; Renal dysfunction; Thrombocytopenia

Indexed keywords

LINEZOLID;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIAL PNEUMONIA; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG BLOOD LEVEL; DRUG CLEARANCE; FEMALE; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MALE; MEDIASTINITIS; PRIORITY JOURNAL; SKIN INFECTION; THROMBOCYTOPENIA; UREA NITROGEN BLOOD LEVEL; WOUND INFECTION;

ACETAMIDES; ADMINISTRATION, ORAL; AGED; ANTI-INFECTIVE AGENTS; BLOOD UREA NITROGEN; CREATININE; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; JAPAN; MALE; OXAZOLIDINONES; RENAL INSUFFICIENCY; RISK FACTORS; THROMBOCYTOPENIA;

EID: 77953807488     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.02.019     Document Type: Article

References (15)

1. Attassi K., Hershberger E., Alam R., Zervos M.J. Thrombocytopenia associated with linezolid therapy. Clin Infect Dis 2002, 34:695-698.
2. Gerson S.L., Kaplan S.L., Bruss J.B., Le V., Arellano F.M., Hafkin B., et al. Hematologic effects of linezolid: summary of clinical experience. Antimicrob Agents Chemother 2002, 46:2723-2726.
3. Wu V.C., Wang Y.T., Wang C.Y., Tsai I.J., Wu K.D., Hwang J.J., et al. High frequency of linezolid-associated thrombocytopenia and anemia among patients with end-stage renal disease. Clin Infect Dis 2006, 42:66-72.
4. Lin Y.H., Wu V.C., Tsai I.J., Ho Y.L., Hwang J.J., Tsau Y.K., et al. High frequency of linezolid-associated thrombocytopenia among patients with renal insufficiency. Int J Antimicrob Agents 2006, 28:345-351.
5. Soriano A., Ortega M., García S., Peñarroja G., Bové A., Marcos M., et al. Comparative study of the effects of pyridoxine, rifampin, and renal function on hematological adverse events induced by linezolid. Antimicrob Agents Chemother 2007, 51:2559-2563.
6. Matsumoto K., Takeda Y., Takeshita A., Fukunaga N., Shigemi A., Yaji K., et al. Renal function as a predictor of linezolid-induced thrombocytopenia. Int J Antimicrob Agents 2009, 33:98-99.
7. Brier M.E., Stalker D.J., Aronoff G.R., Batts D.H., Ryan K.K., O'Grady M., et al. Pharmacokinetics of linezolid in subjects with renal dysfunction. Antimicrob Agents Chemother 2003, 47:2775-2780.
8. Abe S., Chiba K., Cirincione B., Grasela T.H., Ito K., Suwa T. Population pharmacokinetic analysis of linezolid in patients with infectious disease: application to lower body weight and elderly patients. J Clin Pharmacol 2009, 49:1071-1078.
9. Borner K., Borner E., Lode H. Determination of linezolid in human serum and urine by high-performance liquid chromatography. Int J Antimicrob Agents 2001, 18:253-258.
10. Cockcroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 1976, 16:31-41.
11. Yamaoka K., Tanigawara Y., Nakagawa T., Uno T. A pharmacokinetic analysis program (MULTI) for microcomputer. J Pharmacobiodyn 1981, 4:879-885.
12. 14C]linezolid to healthy human subjects. Drug Metab Dispos 2001, 29:1136-1145.
13. Stalker D.J., Jungbluth G.L., Hopkins N.K., Batts D.H. Pharmacokinetics and tolerance of single- and multiple-dose oral or intravenous linezolid, an oxazolidinone antibiotic, in healthy volunteers. J Antimicrob Chemother 2003, 51:1239-1246.
14. Meagher A.K., Forrest A., Rayner C.R., Birmingham M.C., Schentag J.J. Population pharmacokinetics of linezolid in patients treated in a compassionate-use program. Antimicrob Agents Chemother 2003, 47:548-553.
15. Tsuji Y., Hiraki Y., Mizoguchi A., Hayashi W., Kamohara R., Kamimura H., et al. Pharmacokinetics of repeated dosing of linezolid in a hemodialysis patient with chronic renal failure. J Infect Chemother 2008, 14:156-160.